Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-19

Clinical Trial Update: Dentinal Hypersensitivity Reduction Efficacy Study [Phase 3]

View source ↗

Summary

Phase 3 study by Colgate-Palmolive evaluating a toothpaste's effectiveness in reducing dentinal hypersensitivity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Colgate toothpaste

Snippet

Sponsor: Colgate Palmolive | Conditions: Sensitivity, Tooth | Phase 3 | Status: COMPLETED